Twin Lakes Capital Management’s Alterity Therapeutics ATHE Stock Holding History

Twin Lakes Capital Management’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$748K	Hold	139,258	–	–	0.29%	47
2026 Q1	$485K	Hold	139,258	–	–	0.22%	57
2025 Q4	$429K	Hold	139,258	–	–	0.19%	63
2025 Q3	$524K	Buy	139,258 +133,333	+2,250%	+$643K	0.24%	55
2025 Q2	$24.2K	Hold	5,925	–	–	0.01%	163
2025 Q1	$20.4K	Hold	5,925	–	–	0.01%	168
2024 Q4	$19.6K	Hold	5,925	–	–	0.01%	180
2024 Q3	$7.78K	Hold	5,925	–	–	0.01%	205
2024 Q2	$10.7K	Hold	5,925	–	–	0.01%	199
2024 Q1	$12.3K	Hold	5,925	–	–	0.01%	198
2023 Q4	$14.8K	Hold	5,925	–	–	0.01%	188
2023 Q3	$14.7K	Hold	5,925	–	–	0.01%	192
2023 Q2	$16.5K	Hold	5,925	–	–	0.01%	186
2023 Q1	$16.4K	Buy	+5,925	New	+$20.2K	0.01%	185

Other funds holding ATHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PCA

Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

Twin Lakes Capital Management's ATHE Position: Q2 2026 in Review

Twin Lakes Capital Management held its Alterity Therapeutics (ATHE) position steady in Q2 2026 at 139,258 shares worth $748K. The position accounts for 0.29% of the portfolio, ranked #47.

Twin Lakes Capital Management first reported a position in ATHE in Q1 2023 and has held it in 14 quarters since. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

Twin Lakes Capital Management held 139,258 shares of Alterity Therapeutics worth $748K as of Q2 2026.
Twin Lakes Capital Management left its Alterity Therapeutics share count unchanged in Q2 2026.
Alterity Therapeutics made up 0.29% of Twin Lakes Capital Management's portfolio in Q2 2026, its #47 holding.
Twin Lakes Capital Management first reported a position in Alterity Therapeutics in Q1 2023 and has held it in 14 quarters since.
22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.